Frost & Sullivan interview with Chris Henri
As part of Frost & Sullivan’s ongoing analysis of the latest trends impacting healthcare, future changes, and connected healthcare concepts, their principal analyst Nadim Daher recently conducted an interview with Intelerad founder and CTO, Chris Henri.
A former assistant professor of diagnostic radiology and medical physics at McGill University, Chris first became involved in developing radiology solutions in 1995, working alongside Bob Cox (Intelerad founder and Chief Information Officer) and Rick Rubin (Intelerad founder and Chief Engineering Officer) to design, develop and deploy one of Canada’s first large-scale filmless PACS at the Montreal General Hospital.
In this interview, Chris speaks at length in regards to Intelerad’s values, practices and philosophies; developing innovative radiology solutions; providing industry-leading customer support; the company’s role in the ambulatory and hospital markets; and more.
An excerpt from the interview can be found below. If you’d like to read the complete interview, it can be accessed here.
Nadim Daher: Intelerad has traditionally catered mostly to ambulatory providers, but has had some big wins recently in the hospital space. What can you tell us about the reasons behind this move up-market and how this new market opening up bodes for Intelerad?
Chris Henri: Indeed, we are recognized more for what we have accomplished in the ambulatory market, but we didn’t set out originally with this market in mind. In fact, we developed our expertise in a couple large-scale university hospital environments before entering the commercial world. We learned quickly that a small company would have a hard time competing against the large modality vendors for PACS business in hospitals, particularly at the time when hospitals were purchasing PACS for the first time. Fortunately, the ambulatory market found us. But as we grew, we still accumulated some hospital customers and several other types of businesses, too.
Intelerad now has approximately 260 employees and is still growing. We aren’t considered “small” any more, but we are still able to be nimble and responsive to our customers. We have also established some credibility and a good reputation, particularly for delivering robust, large-scale solutions. We have a good story to tell and a very strong referral base.
The timing in the market looks good for solutions which can overcome current challenges in the hospital space. Purchasers of first-generation systems are reflecting on their experiences and reassessing their options. We are hearing people express significant dissatisfaction. We are hearing of broken promises, unfulfilled efficiency gains, high costs, an inability to keep up with evolving changes in business needs, etc. Buying from a big name has proven to not always be the safest (best) choice.
In some ways, we find hospitals to be simpler to implement than what we have faced in the ambulatory market, at least from a technical perspective. And from what we have seen of workflows within hospitals, the bar is set very low. Integrations are often limited or even absent in many cases. Communications between users is poor and inefficient, and a great deal of effort goes into dealing with exceptions or seeking missing information – all signs that the existing solutions are not keeping up with the hospitals’ needs. Integration and interoperability solutions are in high demand by hospitals and are among the things we excel at.
All this to say, I think that this market will respond well to what we have to offer, and likewise, we relish the challenge.